To our surprise, “SCAND3 + Myo1g + AFP” had results that indicated an even more increased diagnostic efficiency for the identification of early HCC, with a corresponding sensitivity of 94% and an AUC of 0.851 (0.794–0.908). This evidence concerns the gene AFP and hepatocellular carcinoma.